John Young

Non Executive / Other Non-Executive
Login/ Register  to follow report
Company: Company:

About

A scientist by training, John D. Young has nearly 35 years of experience in the healthcare industry and brings a wealth of experience in leadership, strategy, business development and commercialization of innovative medicines to the Novartis Board of Directors. He joined Pfizer in 1987 as a sales representative and held positions of increasing seniority across the company, including as a member of Pfizer’s Executive Leadership Team from 2012.

As Pfizer’s Group President and Chief Business Officer from 2019 until 2022, John also played an integral role in the development and delivery of the Pfizer-BioNTech COVID-19 vaccine. Current he is a Board member at Johnson Controls International, Ireland; a Board member at Arvinas Inc, US; and a Board member at Imbria Pharmaceuticals, US. Previously he was a Senior advisor to the CEO at Pfizer, US (January-June 2022); a Group president and chief business officer at Pfizer, US (2019-2022); a Group president, innovative health business at Pfizer, US (2018); a Group president, essential health business at Pfizer, US (2014-2017); a President and general manager, global primary care business unit at Pfizer, US (2012-2013); a Regional president, primary care business unit for Europe and Canada at Pfizer, UK (2009-2012); Various managerial positions, Pfizer, UK and Australia (1987–2008); a Board member at Haleon, UK (2022-February 2023);

Board member at GSK Consumer Health Joint Venture, UK (2019-2022); a Board member at Biotechnology Innovation Organization (BIO), US (2018-2021); a US bio-pharmaceutical representative at UK Government Life Sciences Council, UK (2007-2021); a Board member at National Committee for US China Relations, US (2014-2017); and a Board member at European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium (2012-2017). He has a Master of Business Administration from University of Strathclyde, UK; and a Bachelor of Science in biological sciences from University of Glasgow, UK.

 

Personal Details

Title: Mr
Surname: Young
DoB: 01/01/1964
Age: 62 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: MBA, BSc.Bio
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

CompanyCommitteePositionDate Appointed
BoardMember
BoardMember
BoardMember

 

Working history

Name

Other Official

Pfizer Inc.
Appointed Date: 01/01/1987
Date Resigned: 01/06/2022
Industry: Pharmaceutical

View Company

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
NovartisBoardMember01/01/2023
Johnson Controls InternationalBoardMember01/01/2018
Johnson Controls InternationalAuditMember01/01/2018

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF